| Name | 3-[4-(4-bromophenyl)phenyl]-4-hydroxypyrrole-2,5-dione |
|---|---|
| Synonyms | Glycolic acid oxidase inhibitor 1 |
| Description | Glycolic acid oxidase inhibitor 1 is a glycolate oxidase inhibitor, extracted from patent EP0021228A1, in Table IV. |
|---|---|
| Related Catalog | |
| Target |
Glycolate oxidase[1] |
| In Vivo | Glycolic acid oxidase inhibitor 1 inhibits oxalate biosynthesis in isolated perfused rat liver. Glycolate oxidase inhibitors provide a specific approach to the prevention and treatment of calcium oxalate renal lithiasis[1]. |
| References |
| Density | 1.641g/cm3 |
|---|---|
| Boiling Point | 528.9ºC at 760 mmHg |
| Molecular Formula | C16H10BrNO3 |
| Molecular Weight | 344.16000 |
| Flash Point | 273.7ºC |
| Exact Mass | 342.98400 |
| PSA | 69.89000 |
| LogP | 3.31750 |
| Index of Refraction | 1.688 |
| Storage condition | 2-8℃ |
| Precursor 4 | |
|---|---|
| DownStream 0 | |